We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Branded Drug Cos. Paying Off Generics: FTC Report

Law360 (April 25, 2006, 12:00 AM EDT) -- Spurred by a series of recent legal victories, brand-name drug makers are increasingly collaborating with generic rivals to stall the introduction of cheaper generic drugs to the detriment of consumers, according to a report released this week by the Federal Trade Commission.

The study, which is part of a wider probe into anti-competitive practices in the prescription drug industry, analyzed the twenty agreements that were filed by generic and brand-name drug manufacturers with the FTC in fiscal year 2005.

Of those deals, eleven represented final settlements...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.